Applied DNA and Alphazyme completed Linea™ RNAP manufacturing scale-up, reducing costs by 70%.

Applied DNA and Alphazyme have completed their Linea™ RNAP manufacturing scale-up project, resulting in a 70% reduction in Linea RNAP manufacturing costs. This substantial improvement in Linea IVT platform economics allows Applied DNA to meet their anticipated near-term demand. The collaboration between the two companies in the joint process development project led to the production of sufficient Linea RNAP quantity.